The list below contains Medical Device’s Field Corrective Action for the month of March 2026. This list provides field corrective action reporting information to MDA by establishment in accordance to requirement stipulated in Section 41, Act 737 and Regulation 6 of Medical Device (Duties and Obligations of Establishment) Regulations 2019.

Field Corrective Action (FCA) is part of a post-marketing risk assessment measure to ensure the continued safe use of medical devices in the Malaysia market. It is a corrective or preventive action in relation to a medical device which may include –

  • The return of the medical device to the establishment;
  • Modification of the medical device;
  • Exchange of the medical device;
  • Destruction of medical device; or
  • Specific advice on the use of the medical device. 

If you have experienced any safety and performance issue with one of the medical devices listed for FCA action, please seek advice from your medical device authorised representative as soon as possible.

      MEDICAL DEVICE FIELD CORRECTIVE ACTION LISTING MARCH 2026

No.

Date Received

Title of FCA

Affected Medical Device

MDA Reference Number

MDA Registration Number

Local Establishment Contact Detail

1

02/03/2026

2024-IGT-BST-026 - Philips Azurion potential loss of imaging functionality resulting from no or intermittent X-ray radiation initiation through the wired foot switch.

AZURION 3

 MDA/FCA/P1693-95365592-2026

GC99381544218

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com

2

03/03/2026

2024-IGT-BST-026 - Philips Azurion potential loss of imaging functionality resulting from no or intermittent X-ray radiation initiation through the wired foot switch.

AZURION 5

 MDA/FCA/P1694-24420952-2026

GC10785320-48186

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com  

3

03/03/2026

2024-IGT-BST-026 - Philips Azurion potential loss of imaging functionality resulting from no or intermittent X-ray radiation initiation through the wired foot switch.

AZURION 7

 MDA/FCA/P1695-44042981-2026

GC82521235717

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com

4

03/03/2026

2024-IGT-BST-026 - Philips Azurion potential loss of imaging functionality resulting from no or intermittent X-ray radiation initiation through the wired foot switch.

AZURION BIPLANE

 MDA/FCA/P1696-32986984-2026

GC59959884718

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com

5

04/03/2026

Field Corrective Action on Precipitates Forming in the Reconstitution Buffer within the Test Cartridge of Afinion HbA1c

AFINION HBA1C

 MDA/FCA/P1697-28229741-2026

IVDB67848304818

ABBOTT DIAGNOSTICS HEALTH SDN BHD

winnielinlin.hii@abbott.com

6

05/03/2026

2025-EI-RI-003 - Vue Motion V12 Potential for misdiagnosis due to multi-frame images displaying out of sequence

PHILIPS VUE PACS

 MDA/FCA/P1699-68534877-2026

GB18651834218

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com

7

06/03/2026

Field Safety Corrective Action: Purge Cassette (Generation 1) for Impella System – Increased Risk of Purge Leak Leading to Low Purge Pressure

IMPELLA CP® WITH SMARTASSIST® SET

 MDA/FCA/P1702-89676739-2026

GD9474523-140294

DCH AURIGA (M) SDN BHD

LimLiangJun@dchauriga.com

8

13/03/2026

The value assignment of certain HemosIL Heparin Calibrator lots showed a bias against the WHO International Standards for UFH and LMWH, which could have resulted in reduced recovery when measuring heparin in controls and patient samples.

HEMOSIL LIQUID ANTI-XA

 MDA/FCA/P1707-20692968-2026

IVDC53329234618

STRAITS SCIENTIFIC (M) SDN BHD

straits@3s.com.my

9

18/03/2026

Olympus to Remind Customers of HF Cable IFU Information.

ELECTROSURGICAL GENERATOR ESG-400

 MDA/FCA/P1710-45933338-2026

GC94229142417

OLYMPUS (MALAYSIA) SDN. BHD.

mes-ra.oml@olympus.com

10

19/03/2026

FA1546 Induction of ventricular arrythmia during Sphere-9™ catheter radiofrequency ablation in patients with Biotronik ICDs

AFFERA™ INTEGRATED MAPPING SYSTEM

 MDA/FCA/P1712-31218074-2026

GD9452125-218019

MEDTRONIC MALAYSIA SDN BHD

dl.myreg@medtronic.com

11

24/03/2026

023 FSCA ACHC 26-05 Atellica CH Creatine Kinase (CK_L) | Potential for Falsely Elevated Results with Lot Numbers 252591, 252602 and 252612

ATELLICA® CH CREATINE KINASE (CK_L)

 MDA/FCA/P1717-57493031-2026

IVDC9131423-128501

SIEMENS HEALTHCARE SDN. BHD.

yenli.lam@siemens-healthineers.com  

12

25/03/2026

024 CN AIMC 26-02 Atellica IM and ADVIA Centaur Free Prostate-Specific Antigen (fPSA) | Invalid Calibrations

ATELLICA® IM FREE PROSTATE‑SPECIFIC ANTIGEN (FPSA)

 MDA/FCA/P1718-58514099-2026

IVDC82776266818

SIEMENS HEALTHCARE SDN. BHD.

yenli.lam@siemens-healthineers.com  

13

26/03/2026

Documentation Omission in LIAISON Rubella IgM, 310730 (Missing NFTU)

LIAISON® RUBELLA IGM

 MDA/FCA/P1720-91186536-2026

IVDC8532923-128419

DIAGNOSTICARE SDN BHD

zaidi.jantan@diagnosticare.com.my  

14

26/03/2026

022 FSCA DC 26-01 Dimension Creatinine Flex Reagent Cartridge|

Imprecision with Quality Control and Patient Results for

Dimension Creatinine Lot Numbers GA6307 and BA7005

DIMENSION CREATININE

 MDA/FCA/P1721-13154273-2026

IVDB54125130718

SIEMENS HEALTHCARE SDN. BHD.

yenli.lam@siemens-healthineers.com  

15

27/03/2026

Software Anomaly Causing VITROS™ Systems to Switch From VITROS™ Calibrator Kit 32 to VITROS™ Calibrator Kit 2 During ADD Load

VITROS IMMUNODIAGNOSTIC PRODUCTS FERTILITY & PREGNANCY HORMONES & PROTEINS

 MDA/FCA/P1725-75023993-2026

IVDB7258323-129195

T T MEDICAL MANAGEMENT SDN BHD

ttcsdt05@gmail.com

16

27/03/2026

Reduced Shelf Life of PALAMIX® Mixing System

PALAMIX VACUUM MIXING SYSTEM

MDA/FCA/P1726-81262285-2026

Attachment A )

Attachment B )

GB4398519-36101

ACX HEALTH SDN. BHD.

regulatory.my@pharmatomarket.com

17

30/03/2026

2025-IGT-BST-025 Aneurysm Flow

Potential Safety issue if MAFA ratio is used for clinical decision making

ANEURYSMFLOW

 MDA/FCA/P1727-77143402-2026

GB16499497817

PHILIPS MALAYSIA SENDIRIAN BERHAD

zam.zarina@philips.com

18

30/03/2026

To advise of updates to the Instructions for Use (IFU) to enhance the information for the users - Thoraflex Hybrid

THORAFLEX HYBRID DEVICE

 MDA/FCA/P1728-11622190-2026

GD79535860718

TERUMO MALAYSIA SDN. BHD.

TMSB_RAQ@terumo.co.jp

* The information contained in the Medical Device Authority Field Corrective Action database is released under Regulation 7(8) and Regulation 8(5) of Malaysia’s Medical Device Regulations 2019.